"Chemokine CXCL13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is chemotactic for B-LYMPHOCYTES. It has specificity for CXCR5 RECEPTORS.
| Descriptor ID |
D054382
|
| MeSH Number(s) |
D12.644.276.374.200.120.650 D12.776.467.374.200.120.650 D23.125.300.120.650 D23.469.200.120.650 D23.529.374.200.120.650
|
| Concept/Terms |
Chemokine CXCL13- Chemokine CXCL13
- CXCL13, Chemokine
- SCYB13 Chemokine
- Chemokine, SCYB13
- Chemokine (C-X-C Motif) Ligand 13 (B-Cell Chemoattractant)
- CXCL13 Chemokine
- Chemokine, CXCL13
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL13".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL13".
This graph shows the total number of publications written about "Chemokine CXCL13" by people in this website by year, and whether "Chemokine CXCL13" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL13" by people in Profiles.
-
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia. Leukemia. 2021 06; 35(6):1610-1620.
-
ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC. Sci Transl Med. 2020 06 17; 12(548).
-
Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020 01; 577(7791):561-565.
-
Lymphatic endothelial cells regulate B-cell homing to lymph nodes via a NIK-dependent mechanism. Cell Mol Immunol. 2019 02; 16(2):165-177.
-
Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway. Cell Rep. 2017 04 11; 19(2):375-388.
-
Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis. Oncotarget. 2015 Dec 29; 6(42):44239-53.
-
Macaque paneth cells express lymphoid chemokine CXCL13 and other antimicrobial peptides not previously described as expressed in intestinal crypts. Clin Vaccine Immunol. 2013 Aug; 20(8):1320-8.
-
Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 2013 Sep; 6(5):972-84.
-
IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol. 2011 Nov 15; 187(10):5402-7.
-
Angioimmunoblastic T-cell lymphoma in bone marrow: a morphologic and immunophenotypic study. Hum Pathol. 2010 Jan; 41(1):79-87.